STAT

The end to animal testing marks the beginning of better biomedicine

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...
JD Supra

FDA animal testing phaseout urges AI-based trial alternatives, organoids, other “NAMs”

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...
Yahoo

To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods

FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods and artificial intelligence to determine drug safety and effectiveness.
FierceBiotech

FDA plans to end animal testing requirements for monoclonal antibody drugs

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...
Healio

FDA takes steps to reduce animal testing requirements for monoclonal antibodies

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...
Ventura County Star

Dr. Loh: Caution needed before phasing out animal testing of new medications

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new drugs, and instead be using “more effective, human-relevant methods” such as ...
STAT

STAT readers on animal models, sexual assault kits, and more

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
Yahoo

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...
Washington Examiner

NIH stops requests for new studies solely relying on animal testing

The National Institutes of Health announced on Monday that the biomedical agency will no longer put out new funding opportunities solely relying upon animal testing and will require that applicants ...
FierceBiotech

Former FDA leader to chair Charles River advisory board on animal testing alternatives

As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its development of new approach methodologies (NAMs) that can ...
The Scientist

FDA Announces Plan to Phase Out Animal Testing. Will That Work?

In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...